Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00097240 · ClinicalTrials.gov registry record
An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)
A clinical trial of Pregnancy and Psoriasis, sponsored by Genentech.
- Completed
- Registry status
- 18
- Enrollment target
- 1
- Study location
NCT00097240: Completed study of Pregnancy and Psoriasis, sponsored by Genentech.
NCT00097240 is a study of Pregnancy and Psoriasis that has completed, run by Genentech. The registered enrollment target is 18 participants, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00097240, a study of Pregnancy and Psoriasis, has completed, sponsored by Genentech.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The Raptiva Pregnancy Registry was a prospective observational study established to obtain data on pregnancy outcomes of women who were exposed to Raptiva.
Study Locations (1)
North Carolina
- FOLLOW Raptiva Pregnancy Registry - Morrisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2005-01 |
| Est. Completion | 2009-09 |
What the finished NCT00097240 record still lists
NCT00097240 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 0 interventions.
NCT00097240 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00097240 about?
NCT00097240 is a clinical study titled "An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)". The Raptiva Pregnancy Registry was a prospective observational study established to obtain data on pregnancy outcomes of women who were exposed to Raptiva.
What is the current status of trial NCT00097240?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2005-01. Estimated completion is 2009-09.
What conditions does trial NCT00097240 study?
This clinical trial studies the following conditions: Pregnancy, Psoriasis.
Who is sponsoring clinical trial NCT00097240?
This trial is sponsored by Genentech, which has 332 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00097240 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00097240's enrollment target sits among peer trials
18 183rd of 191 higher than 9 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia